BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37521470)

  • 1. Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.
    Lum PT; Sekar M; Seow LJ; Shaikh MF; Arulsamy A; Retinasamy T; Gan SH; Gnanaraj C; Esa NM; Ramachawolran G; Subramaniyan V; Chinni SV; Wu YS
    Front Pharmacol; 2023; 14():1189957. PubMed ID: 37521470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
    Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
    Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters.
    Jamwal S; Kumar P
    Physiol Behav; 2016 Mar; 155():180-7. PubMed ID: 26703234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
    Kumar P; Kalonia H; Kumar A
    Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.
    Lum PT; Sekar M; Gan SH; Bonam SR; Shaikh MF
    ACS Chem Neurosci; 2021 Feb; 12(3):391-418. PubMed ID: 33475334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Fustin against Huntington's Disease in 3-Nitropropionic Treated Rats via Downregulation of Oxidative Stress and Alteration in Neurotransmitters and Brain-Derived Neurotrophic Factor Activity.
    Bin-Jumah MN; Gilani SJ; Alabbasi AF; Al-Abbasi FA; AlGhamdi SA; Alshehri OY; Alghamdi AM; Sayyed N; Kazmi I
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
    PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.
    Afzal M; Sayyed N; Alharbi KS; Alzarea SI; Alshammari MS; Alomar FA; Alenezi SK; Quazi AM; Alzarea AI; Kazmi I
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892333
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington's Disease.
    Albekairi TH; Kamra A; Bhardwaj S; Mehan S; Giri A; Suri M; Alshammari A; Alharbi M; Alasmari AF; Narula AS; Kalfin R
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway.
    Abdel Rasheed NO; Ibrahim WW
    Life Sci; 2022 May; 297():120480. PubMed ID: 35278421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
    Sidhu A; Diwan V; Kaur H; Bhateja D; Singh CK; Sharma S; Padi SSV
    Metab Brain Dis; 2018 Dec; 33(6):1911-1921. PubMed ID: 30054774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway.
    Ibrahim WW; Abdel Rasheed NO
    Inflammopharmacology; 2022 Oct; 30(5):1745-1758. PubMed ID: 35639233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.